Moody's Places Hospira's (HSP) Ratings on Review for Upgrade (PFE)
Go back to Moody's Places Hospira's (HSP) Ratings on Review for Upgrade (PFE)| Hospira Inc. (NYSE: HSP) | Delayed: 89.95 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $89.95 | 52 Week High | $90.63 | |||
| Open | $3.49 | 52 Week Low | $46.56 | |||
| Day High | $89.95 | P/E | N/A | |||
| Day Low | $89.95 | EPS | $-0.05 | |||
| Volume | 24,251 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 27.66 +0.02 (0.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.64 | 52 Week High | $37.39 | |||
| Open | $27.64 | 52 Week Low | $28.25 | |||
| Day High | $27.66 | P/E | 16.76 | |||
| Day Low | $27.34 | EPS | $1.65 | |||
| Volume | 75,587,710 | |||||
